PE firm buys stake from ChrysCapital in a transaction that values Intas Pharmaceuticals at about $3.5 billion
Mumbai: Capital International Private Equity Fund has acquired about 3% of Intas Pharmaceuticals Ltd for $107 million (Rs690 crore) from ChrysCapital Llc., according to two people aware of the development.
Recommended For You
Select your Category
Internet Not Available
Wait for it…
Log in to our website to save your bookmarks. It'll just take a moment.